Alumis Inc. Files 2024 Annual Report Amendment
Ticker: ALMS · Form: 10-K/A · Filed: Apr 23, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 10-K/A |
| Filed Date | Apr 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Alumis Inc. filed its 2024 10-K amendment, check for updates on their pharma biz.
AI Summary
Alumis Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly Esker Therapeutics, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector. The filing was made on April 23, 2025, and pertains to the fiscal year ending December 31, 2024.
Why It Matters
This amendment provides updated financial and operational information for Alumis Inc., crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Alumis Inc. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 001-42143 — SEC File Number (Identifies the company's filings with the SEC)
- 86-1771129 — EIN (Employer Identification Number)
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-04-23 (date) — Filing date
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA 94080 (address) — Business and mail address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, indicating updates or corrections to the original filing.
When was this amendment filed with the SEC?
This amendment was filed on April 23, 2025.
What was Alumis Inc.'s former company name?
Alumis Inc.'s former company name was Esker Therapeutics, Inc., with a name change date of April 27, 2023.
Where is Alumis Inc. headquartered?
Alumis Inc.'s business and mail address is 280 East Grand Avenue, South San Francisco, CA 94080.
What is Alumis Inc.'s Standard Industrial Classification (SIC) code?
Alumis Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 23, 2025 regarding ALUMIS INC. (ALMS).